F. Mihaltan (Bucuresti, Romania), J. Lopez-Campos Bodineau (Sevilla, Spain), S. Bhatt (Birmingham, United States of America), A. Olin (Göteborg, Sweden)
Frailty in COPD inpatients, does it affect length of stay and mortality?
B. Bradley (Chichester, United Kingdom), H. Nguyen (Chichester, United Kingdom), Z. Cashin (Chichester, United Kingdom)
|   |
Identification of clinical phenotypes using cluster analyses in COPD patients
A. Corlateanu (Chisinau, Republic of Moldova), E. Scutaru (Chisinau, Republic of Moldova), D. Rusu (Chisinau, Republic of Moldova), O. Corlateanu (Chisinau, Republic of Moldova), S. Covantev (Chisinau, Republic of Moldova), V. Botnaru (Chisinau, Republic of Moldova)
| |
Phenotyping emphysema – are there gender aspects?
S. Kühne (Berlin, Germany), P. Hoffmann (Berlin, Germany), C. Hoffmann (Berlin, Germany), B. Lassen-Schmidt (Bremen, Germany), C. Rott (Mannheim, Germany), C. Witt (Berlin, Germany), U. Liebers (Berlin, Germany)
| |
COPD in women: a particular phenotype
K. Ayed (Ariana, Tunisia), S. Khaldi (Ariana, Tunisia), S. Mokaddem (Ariana, Tunisia), A. Chaker (Ariana, Tunisia), I. Hadj Khalifa (Ariana, Tunisia), N. Oueslati (Ariana, Tunisia), S. Ben Khamsa Jamaleddine (Ariana, Tunisia)
| |
Gender-dependent predictors for survival in patients with COPD
C. Gösser (Essen, Germany), H. Teschler (Essen, Germany), C. Taube (Essen, Germany), G. Weinreich (Essen, Germany)
| |
Gender differences in patients with severe asthma in real-life setting: data from the Severe Asthma Network in Italy (SANI) registry
G. Senna (Verona, Italy), E. Heffler (Milano, Italy), F. Puggioni (Milano, Italy), M. Latorre (Pisa, Italy), M. Caminati (Verona, Italy), F. Blasi (Milano, Italy), P. Paggiaro (Pisa, Italy), G. Canonica (Milano, Italy)
| |
The impact of decreased 6MWT and exercise-induced desaturation on long-term survival and mortality related to Czech and Spanish phenotypes in patients with severe COPD
M. Plutinsky (Brno, Czech Republic), K. Brat (Brno, Czech Republic), M. Svoboda (Brno, Czech Republic), P. Popelkova (Ostrava, Czech Republic), E. Volakova (Olomouc, Czech Republic), J. Zatloukal (Olomouc, Czech Republic), B. Novotna (Praha, Czech Republic), T. Dvorak (Mlada Boleslav, Czech Republic), P. Vanik (Ceske Budejovice, Czech Republic), P. Musilova (Jihlava, Czech Republic), O. Kudela (Hradec Kralove, Czech Republic), K. Neumannova (Olomouc, Czech Republic), E. Kocova (Hradec Kralove, Czech Republic), M. Skrobackova (Brno, Czech Republic), V. Koblizek (Hradec Kralove, Czech Republic)
| |
Frequent COPD exacerbators are not a stabile phenotype
I. Krachunov (Pleven, Bulgaria), Z. Ivanova (Pleven, Bulgaria), N. Kyuchukov (Pleven, Bulgaria), P. Pavlov (Pleven, Bulgaria), P. Glogovska (Pleven, Bulgaria), T. Popova (Pleven, Bulgaria), Y. Ivanov (Pleven, Bulgaria)
| |
Exacerbation phenotypes of frequent versus non-frequent exacerbators among severe asthma patients
K. Soenjoyo (Singapore, Singapore), N. Nadkarni (Singapore, Singapore), A. Fang (Singapore, Singapore), M. Koh (Singapore, Singapore)
| |
Are comorbidities related to frequent severe exacerbations of COPD?
D. Mülazimoglu (Ankara, Turkey), S. Ayöz (Ankara, Turkey), B. Bilgin (Ankara, Turkey), F. Çiftçi (Ankara, Turkey), E. Sen (Ankara, Turkey)
| |
Distinct asthma phenotypes in a multi-ethnic asian population
T. Tay (Singapore, Singapore), X. Choo (Singapore, Singapore), H. Wong (Singapore, Singapore), A. Yii (Singapore, Singapore), Y. Chan (Singapore, Singapore), A. Chan (Singapore, Singapore), A. Tee (Singapore, Singapore), M. Koh (Singapore, Singapore)
| |
The prevalence of restless leg syndrome in chronic obstructive pulmonary diseases(COPD) patients
H. Raji (Ahvaz, Islamic Republic of Iran), M. Momeni (Zahedan, Islamic Republic of Iran), S. Javadmoosavi (Tehran, Islamic Republic of Iran)
| |
Reducing the risk of COPD exacerbations as results of personalized therapy of co-morbidity with upper respiratory tract diseases
V. Nevzorova (Vladivostok, Russian Federation), E. Gilifanov (Vladivostok, Russian Federation), I. Martynenko (Vladivostok, Russian Federation), D. Pavlus (Vladivostok, Russian Federation)
| |
The risk of hyperkalemia in COPD and asthma patients
J. Mäenpää (Gothenburg, Sweden), U. Emerath (Gothenburg, Sweden), S. Sultana (Cambridge, United Kingdom), M. Olsson (Gothenburg, Sweden), M. Carlsson (Gothenburg, Sweden)
| |
Incidence of COPD in a sample of patients with psychosis: preliminary data from a 10 years longitudinal study
A. Viejo (Santander, Spain), J. Vázquez-Bourgon (Santander, Spain), C. Amado Diago (Santander, Spain), B. Durantes Gómez (Santander, Spain), M. Ruiz Nuñez (Santander, Spain), R. Garrastazu López (Santander, Spain), M. Ibañez Alario (Santander, Spain), S. Somonte Segares (Santander, Spain), L. Sánchez Blanco (Santander, Spain), R. Romero Jiménez (Santander, Spain), B. Crespo Facorro (Santander, Spain)
| |
Do DECAF scores for acute exacerbation of COPD correlate with hospital anxiety and depression scale?
N. Shah (Bolton, United Kingdom), K. Ibrahim (Bolton, United Kingdom), S. Khurana (Bolton, United Kingdom), R. Yadavilli (Bolton, United Kingdom)
| |
Breathless and blue: are anxiety and depression underdiagnosed in severe asthma?
R. ALSUWAIGH (Singapore, Singapore), C. Tay (Singapore, Singapore), W. Chew (Singapore, Singapore), M. Shi (Singapore, Singapore), A. Fang (Singapore, Singapore), M. Koh (Singapore, Singapore)
| |
Comorbidities in chronic obstructive pulmonary disease: Prognostic factors?
H. Zaibi (Tunis, Tunisia), R. Fessi (Tunis, Tunisia), S. Maazaoui (Tunis, Tunisia), E. Ben Jemai (Tunis, Tunisia), A. Jarrar (Tunis, Tunisia), N. Guediri (Tunis, Tunisia), B. Ourari (Tunis, Tunisia), J. Ben Amar (Tunis, Tunisia), H. Aouina (Tunis, Tunisia)
| |
Glomerular filtration rate estimated using serum creatinine and cystatin c, and Creatinine Cleareance measured in COPD patients.
C. Amado Diago (Santander, Spain), M. Garcia-Unzueta (Santander, Spain), M. Ruiz De Infante (Santander, Spain), B. Lavin (Santander, Spain), R. Guerra (Santander, Spain), J. Agüero (Santander, Spain), B. Abascal (Santander, Spain), S. Tello (Santander, Spain), K. Escobar (Santander, Spain), S. Izquierdo (Santander, Spain), G. Andretta (Santander, Spain), B. Durantes (Santander, Spain)
| |
Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease.
E. Klester (Barnaul, Russian Federation), K. Klester (Barnaul, Russian Federation)
| |